|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
19 February 2015 |
|
Main ID: |
NCT00139945 |
|
Date of registration:
|
30/08/2005 |
|
Prospective Registration:
|
Yes |
|
Primary sponsor: |
|
|
Public title:
|
Ghrelin, Growth Hormone and Cortisol Interaction in Growth Hormone Deficient Patients
|
|
Scientific title:
|
Effects of Acute Ghrelin Infusion to Growth Hormone Deficient Adults: Growth Hormone and Cortisol Interaction |
|
Date of first enrolment:
|
October 2005 |
|
Target sample size:
|
8 |
|
Recruitment status: |
Completed |
|
URL:
|
http://clinicaltrials.gov/show/NCT00139945 |
|
Study type:
|
Interventional |
|
Study design:
|
Allocation: Randomized, Endpoint Classification: Pharmacokinetics/Dynamics Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment
|
|
Phase:
|
N/A
|
|
|
Countries of recruitment
|
|
Denmark
| | | | | | | |
|
Contacts
|
|
Name:
|
Jens Otto L Jorgensen, DrMedSci |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Aarhus University Hospital |
| | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Age between 18 and 60 yrs.
- Verified hypopituitarism
- Unchanged substitution treatment through 3+ months
- Unchanged additional medical treatment
- Oral and written informed consent
Exclusion Criteria:
- Age below 18 or above 60 yrs.
- Diabetes mellitus
- body mass index > 30
- Fasting hypoglycemia
- Convulsions
- Allergy to trial products
Age minimum:
18 Years
Age maximum:
60 Years
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
Hypopituitarism
|
|
Intervention(s)
|
|
Drug: Human acylated ghrelin
|
|
Primary Outcome(s)
|
|
Endogenous serum ghrelin levels
[Time Frame: Same day as intervention]
|
|
Secondary Outcome(s)
|
|
Insulin sensitivity, appetite, metabolism, intracellular signal transduction
[Time Frame: Same day as intervention]
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|